ScinoPharm Taiwan Ltd 2024 Annual Report with Sustainability Disclosures
Company: ScinoPharm Taiwan Ltd
Sector: Manufacturing
Country: Taiwan
Year: 2024
Type: Annual Report with Sustainability Disclosures
Pages: 178
The report describes how ScinoPharm navigated 2024 with consolidated revenue of NT$3.406 billion and continued growth in API, formulation, and CDMO activities. It details a Sustainable Development Committee chaired by the President and reporting annually to the Board of Directors. Climate disclosures cover Scope 1 and 2 emissions, a planned reduction trajectory, renewable-energy projects, water and waste management, and climate-risk assessment using TCFD and IFRS S2 frameworks. The company and its subsidiaries reported a 2024 workforce of 964.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.